Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard Langley

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Dermatology (Basel, Switzerland)|July 15, 2010
Skin and nail responses after 1 year of infliximab therapy in patients with moderate-to-severe psoriasis: a retrospective analysis of the EXPRESS TrialKristian Reich, Jean-Paul Ortonne, Urs Kerkmann, et al.
Journal of Cutaneous Medicine and Surgery|October 16, 2009
Canadian practical guide for the treatment and management of atopic dermatitisCharles Lynde, Kirk Barber, Joel Claveau, et al.
Journal of Cutaneous Medicine and Surgery|January 8, 2010
Update on alefacept safetyDenise Wexler, Gordon Searles, Ian Landells, et al.
Clinical Pharmacology in Drug Development|June 2, 2018
Pharmacokinetic Characteristics of Tofacitinib in Adult Patients With Moderate to Severe Chronic Plaque PsoriasisGuangli Ma, Rujia Xie, Bruce Strober, et al.
Journal of Cutaneous Medicine and Surgery|January 19, 2005
Incorporating biologics into the treatment of psoriasisHarvey Lui, Richard Langley, Yves Poulin, et al.
Dermatology and Therapy|November 22, 2025
Is Cumulative Life Course Impairment Considered in Psoriasis Management? A Multinational Survey of People with Psoriasis and Healthcare ProfessionalsRaymond Matthews, April W Armstrong, Matthias Augustin, et al.
Dermatology (Basel, Switzerland)|August 8, 2008
Recommendations for the long-term treatment of psoriasis with infliximab: a dermatology expert group consensusKristian Reich, Christopher Griffiths, Jonathan Barker, et al.
Journal of the American Academy of Dermatology|February 8, 2024
Vaccination recommendations for adults receiving biologics and oral therapies for psoriasis and psoriatic arthritis: Delphi consensus from the medical board of the National Psoriasis FoundationVipawee S Chat, Christoph T Ellebrecht, Paige Kingston, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Dermatology (Basel, Switzerland)|July 15, 2010
Skin and nail responses after 1 year of infliximab therapy in patients with moderate-to-severe psoriasis: a retrospective analysis of the EXPRESS TrialKristian Reich, Jean-Paul Ortonne, Urs Kerkmann, et al.
Journal of Cutaneous Medicine and Surgery|October 16, 2009
Canadian practical guide for the treatment and management of atopic dermatitisCharles Lynde, Kirk Barber, Joel Claveau, et al.
Journal of Cutaneous Medicine and Surgery|January 8, 2010
Update on alefacept safetyDenise Wexler, Gordon Searles, Ian Landells, et al.
Clinical Pharmacology in Drug Development|June 2, 2018
Pharmacokinetic Characteristics of Tofacitinib in Adult Patients With Moderate to Severe Chronic Plaque PsoriasisGuangli Ma, Rujia Xie, Bruce Strober, et al.
Journal of Cutaneous Medicine and Surgery|January 19, 2005
Incorporating biologics into the treatment of psoriasisHarvey Lui, Richard Langley, Yves Poulin, et al.
Dermatology and Therapy|November 22, 2025
Is Cumulative Life Course Impairment Considered in Psoriasis Management? A Multinational Survey of People with Psoriasis and Healthcare ProfessionalsRaymond Matthews, April W Armstrong, Matthias Augustin, et al.
Dermatology (Basel, Switzerland)|August 8, 2008
Recommendations for the long-term treatment of psoriasis with infliximab: a dermatology expert group consensusKristian Reich, Christopher Griffiths, Jonathan Barker, et al.
Journal of the American Academy of Dermatology|February 8, 2024
Vaccination recommendations for adults receiving biologics and oral therapies for psoriasis and psoriatic arthritis: Delphi consensus from the medical board of the National Psoriasis FoundationVipawee S Chat, Christoph T Ellebrecht, Paige Kingston, et al.
Pageof 2